课题基金 / 基金详情

ACTG 366: NOVEL ANTIRETROVIRAL THERAPY IN ANTIRETROVIRAL EXP CHILD

ACTG 366: NOVEL ANTIRETROVIRAL THERAPY IN ANTIRETROVIRAL EXP CHILD
ACTG 366:抗逆转录病毒治疗儿童的新型抗逆转录病毒疗法
批准号:
6264294
负责人:
ELIZABETH G MCFARLAND
金额:
$1.99万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30

项目摘要

项目成果

ELIZABETH G MCFARLAND的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This trial is designed to evaluate whether four drug combination therapies based on prior antiretroviral experience can maximally decrease viral load and increase CD4 cells. The primary objectives are 1) to determine the proportion of subjects in each Group having reduction in HIV-1 RNA when all antiretroviral agents are changed and at least 2 of the agents are novel and to determine the duration of the reduction; 2) To evaluate the safety and tolerance of these combinations based on clinical and laboratory toxicities; and 3) to determine the steady-state pharmacokinetics of nevirapine, nelfinavir and ritonavir when used in combination with respect to age and treatment group.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ACTG 219--PEDIATRIC HIV LATE OUTCOMES PROTOCOL
  • 批准号:
    6114937
  • 项目类别:
  • 资助金额:
    $1.99万
  • 财政年份:
    1998
  • 负责人:
    ELIZABETH G MCFARLAND
  • 依托单位:
PHASE I/II TRIAL OF RECOMBINANT INTERLEUKIN 2 IN SYMPTOMATIC HIV INFECTED CHILD
  • 批准号:
    6114989
  • 项目类别:
  • 资助金额:
    $1.99万
  • 财政年份:
    1998
  • 负责人:
    ELIZABETH G MCFARLAND
  • 依托单位:
ACTG 273: HIVIG IN SLOWING DISEASE PROGRESSION IN HIV INFECTED CHILD
  • 批准号:
    6264279
  • 项目类别:
  • 资助金额:
    $1.99万
  • 财政年份:
    1998
  • 负责人:
    ELIZABETH G MCFARLAND
  • 依托单位:
ACTG#316--PHASE III NEVIRAPINE FOR PREVENTION OF MATERNAL-FETAL TRANS. OF HIV
  • 批准号:
    6114994
  • 项目类别:
  • 资助金额:
    $1.99万
  • 财政年份:
    1998
  • 负责人:
    ELIZABETH G MCFARLAND
  • 依托单位:
海外基金